Clinical Trial Update: A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating romidepsin in combination with gemcitabine in pancreatic and other advanced solid tumors has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Solid Tumors

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Romidepsin (romidepsin)

Snippet

Sponsor: Celgene | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2012-08-13